Stay updated with breaking news from Augmedix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 24,778 shares of the firm’s stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $3.93, for a total value of $97,377.54. Following the completion of the sale, the insider now owns 3,000 shares of the company’s […] ....
Augmedix, Inc. (NASDAQ:AUGX – Get Free Report) insider Ian Shakil sold 37,780 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $3.97, for a total value of $149,986.60. Following the transaction, the insider now owns 3,000 shares in the company, valued […] ....
Augmedix (NASDAQ:AUGX – Get Free Report) was upgraded by analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a report issued on Tuesday, Benzinga reports. The firm presently has a $5.00 price objective on the stock, up from their previous price objective of $4.50. Evercore ISI’s target price indicates a potential […] ....
B. Riley initiated coverage on shares of Augmedix (NASDAQ:AUGX – Free Report) in a report issued on Wednesday morning, Marketbeat reports. The firm issued a buy rating and a $5.50 target price on the stock. B. Riley also issued estimates for Augmedix’s Q1 2024 earnings at ($0.12) EPS, Q2 2024 earnings at ($0.13) EPS, Q3 […] ....
Augmedix (NASDAQ:AUGX – Get Free Report) and Heritage Global (NASDAQ:HGBL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability and earnings. Risk & Volatility Augmedix has a beta of […] ....